Skip to main content
Article thumbnail
Location of Repository

Predictors of appropriate ICD therapy in patients with implantable cardioverter-defibrillator

By Mohammad Reza Dehghani, Arash Arya, Majid Haghjoo, Zahra Emkanjoo, Mohammad Alasti, Babak Kazemi, Mohammad Hosein Nikoo and Mohammad Ali Sadr-Ameli
Topics: Original Article
Publisher: Indian Pacing and Electrophysiology Group
OAI identifier: oai:pubmedcentral.nih.gov:1501091
Provided by: PubMed Central

Suggested articles

Citations

  1. (2003). A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure:
  2. (2002). American College of Cardiology/American Heart Association Task Force on Practice Guidelines American College of Cardiology/American Heart Association/North American Society for Pacing and Electrophysiology Committee. ACC/AHA/NASPE
  3. (2002). Benefits of beta-blocker therapy for heart failure: weighing the evidence. Arch Intern Med.
  4. (2002). Clinical characteristics and survival of patients with chronic heart failure and prolonged QRS duration.
  5. (1998). Electrical storm in patients with transvenous implantable cardioverterdefibrillators: Incidence, management and prognostic implications. J Am Coll Cardiol.
  6. (1996). Five-year experience with implantable defibrillators in children.
  7. (2004). High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator. Pacing Clin Electrophysiol.
  8. (1996). Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl Med.
  9. (2002). Incremental changes in QRS duration in serial ECGs over time identify high risk elderly patients with heart failure.
  10. (1993). Influence of the automatic implantable cardioverter-defibrillator on the long-term prognosis of survivors of out-of-hospital cardiac death. Circulation.
  11. (2000). Is electrical storm in ICD patients the sign of a dying heart? Outcome of patients with clusters of ventricular arrhythmias.
  12. (2000). Long-term mortality after acute myocardial infarction in relation to prescribed dosages of a beta-blocker at hospital discharge. Cardiovasc Drugs Ther.
  13. (2004). Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy a solution to the multicenter automatic defibrillator implantation trial (MADIT) II conundrum. Circulation.
  14. (2002). Predictors of appropriate implantable cardioverter-defibrillator therapy in patients with idiopathic dilated cardiomyopathy.
  15. (1994). Preliminary experience with nonthoracotomy implantable cardioverter defibrillators in young patients. Pacing Clin Electrophysiol.
  16. (2003). QRS duration and prediction of mortality in patients undergoing risk stratification for ventricular arrhythmias.
  17. (2005). Risk stratification for arrhythmic death after myocardial infarction: Current perspective and future direction.
  18. (2003). Role of Amiodarone in the Era of the Implantable Cardioverter Defibrillator. J Cardiovasc Electrophysiol.
  19. (1997). The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from nearfatal ventricular arrhythmias. N Engl Med.
  20. (2002). Usefulness of QRS duration in the absence of bundle branch block as an early predictor of survival in non-ST elevation acute myocardial infarction.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.